Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.

NCT00211484 is registered in ClinicalTrials.gov with Manhattan Eye, Ear & Throat Hospital as lead sponsor.

NCT NCT00211484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00211484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Conditions With Open Label-Anecortave Acetate Sterile Suspension ( 15mg.) Where Lesions do Not Meet Acceptable Criteria for Standard Care.
Lead sponsor
Manhattan Eye, Ear & Throat Hospital
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2003
Completion date
March 31, 2007
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degenerations., subfoveal neovascularization.